Icon (ICLR) Net Income towards Common Stockholders Growth (5y) (2014 - 2026)
Powered by 
Analysis
Icon (ICLR) Net Income towards Common Stockholders Growth (5y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.38 Bn | 40.30 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 16.51 Bn | 16.01 Bn | 201.64 Mn |
| 3 | Charles River Laboratories International | 13.16 Bn | 12.97 Bn | 452.07 Mn |
| 4 | Icon | 12.39 Bn | 11.46 Bn | 479.29 Mn |
| 5 | Fortrea Holdings | 1.57 Bn | 1.40 Bn | 139.20 Mn |
| 6 | Evotec SE | 621.88 Mn | 196.00 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 419.14 Mn | 334.60 Mn | 18.44 Mn |
| 8 | Champions Oncology | 71.79 Mn | 71.79 Mn | 7.03 Mn |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.09% |
| Mar 31, 2026 | 3.00% |
| Dec 31, 2025 | 5.28% |
| Sep 30, 2025 | 16.78% |
| Jun 30, 2025 | 35.85% |
| Mar 31, 2025 | 20.92% |
| Dec 31, 2024 | 17.32% |
| Sep 30, 2024 | 18.10% |
| Jun 30, 2024 | 21.69% |
| Mar 31, 2024 | 20.75% |
| Dec 31, 2023 | 16.96% |
| Sep 30, 2023 | 19.69% |
| Jun 30, 2023 | 23.33% |
| Mar 31, 2023 | 18.50% |
| Dec 31, 2022 | 20.05% |
| Sep 30, 2022 | 17.52% |
| Jun 30, 2022 | 11.03% |
| Mar 31, 2022 | 8.04% |
| Dec 31, 2021 | 3.65% |
| Sep 30, 2021 | -26.09% |